
### [NCIT:C3556](http://purl.obolibrary.org/obo/NCIT_C3556)
**Label:** Malignant Uterine Corpus Neoplasm

**Subclasses:** [NCIT:C6339](http://purl.obolibrary.org/obo/NCIT_C6339) (Uterine Corpus Sarcoma), [NCIT:C27850](http://purl.obolibrary.org/obo/NCIT_C27850) (Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells), [NCIT:C6336](http://purl.obolibrary.org/obo/NCIT_C6336) (Uterine Corpus Adenosarcoma), [NCIT:C27815](http://purl.obolibrary.org/obo/NCIT_C27815) (Malignant Endometrial Neoplasm), [NCIT:C132294](http://purl.obolibrary.org/obo/NCIT_C132294) (Recurrent Endometrial Serous Adenocarcinoma), [NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma), [NCIT:C40223](http://purl.obolibrary.org/obo/NCIT_C40223) (Uterine Corpus Low Grade Endometrial Stromal Sarcoma), [NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40144](http://purl.obolibrary.org/obo/NCIT_C40144) (Endometrial Mucinous Adenocarcinoma), [NCIT:C40145](http://purl.obolibrary.org/obo/NCIT_C40145) (Type I Endometrial Adenocarcinoma), [NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma), [NCIT:C127058](http://purl.obolibrary.org/obo/NCIT_C127058) (Uterine Corpus Rhabdomyosarcoma), [NCIT:C8719](http://purl.obolibrary.org/obo/NCIT_C8719) (Endometrial Squamous Cell Carcinoma), [NCIT:C7359](http://purl.obolibrary.org/obo/NCIT_C7359) (Endometrial Adenocarcinoma), [NCIT:C7558](http://purl.obolibrary.org/obo/NCIT_C7558) (Endometrial Carcinoma), [NCIT:C27849](http://purl.obolibrary.org/obo/NCIT_C27849) (Oxyphilic Endometrial Endometrioid Adenocarcinoma), [NCIT:C27846](http://purl.obolibrary.org/obo/NCIT_C27846) (Villoglandular Endometrial Endometrioid Adenocarcinoma), [NCIT:C40219](http://purl.obolibrary.org/obo/NCIT_C40219) (Uterine Corpus Endometrial Stromal Sarcoma), [NCIT:C27844](http://purl.obolibrary.org/obo/NCIT_C27844) (Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component), [NCIT:C9179](http://purl.obolibrary.org/obo/NCIT_C9179) (Stage IV Uterine Sarcoma AJCC v7), [NCIT:C27845](http://purl.obolibrary.org/obo/NCIT_C27845) (Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component), [NCIT:C6340](http://purl.obolibrary.org/obo/NCIT_C6340) (Uterine Corpus Leiomyosarcoma), [NCIT:C27843](http://purl.obolibrary.org/obo/NCIT_C27843) (Endometrial Endometrioid Adenocarcinoma with Clear Cell Change), [NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma), [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer), [NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma), [NCIT:C9180](http://purl.obolibrary.org/obo/NCIT_C9180) (Uterine Corpus Carcinosarcoma), [NCIT:C39749](http://purl.obolibrary.org/obo/NCIT_C39749) (Type II Endometrial Adenocarcinoma), [NCIT:C126772](http://purl.obolibrary.org/obo/NCIT_C126772) (Endometrial Large Cell Neuroendocrine Carcinoma), [NCIT:C8258](http://purl.obolibrary.org/obo/NCIT_C8258) (Stage I Uterine Sarcoma AJCC v7), [NCIT:C27838](http://purl.obolibrary.org/obo/NCIT_C27838) (Endometrial Serous Adenocarcinoma), [NCIT:C8259](http://purl.obolibrary.org/obo/NCIT_C8259) (Stage II Uterine Sarcoma AJCC v7), [NCIT:C6311](http://purl.obolibrary.org/obo/NCIT_C6311) (Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C8972](http://purl.obolibrary.org/obo/NCIT_C8972) (Uterine Corpus Undifferentiated Sarcoma), [NCIT:C8261](http://purl.obolibrary.org/obo/NCIT_C8261) (Recurrent Uterine Corpus Sarcoma), [NCIT:C8260](http://purl.obolibrary.org/obo/NCIT_C8260) (Stage III Uterine Sarcoma AJCC v7), [NCIT:C9072](http://purl.obolibrary.org/obo/NCIT_C9072) (Recurrent Uterine Corpus Carcinoma), [NCIT:C27839](http://purl.obolibrary.org/obo/NCIT_C27839) (Endometrial Endometrioid Adenocarcinoma, Secretory Variant), [NCIT:C114656](http://purl.obolibrary.org/obo/NCIT_C114656) (Endometrial Adenosquamous Carcinoma), [NCIT:C8942](http://purl.obolibrary.org/obo/NCIT_C8942) (Metastatic Endometrial Adenocarcinoma), [NCIT:C6287](http://purl.obolibrary.org/obo/NCIT_C6287) (Endometrial Endometrioid Adenocarcinoma), [NCIT:C8028](http://purl.obolibrary.org/obo/NCIT_C8028) (Endometrial Clear Cell Adenocarcinoma), [NCIT:C126998](http://purl.obolibrary.org/obo/NCIT_C126998) (Uterine Corpus High Grade Endometrial Stromal Sarcoma), [NCIT:C6290](http://purl.obolibrary.org/obo/NCIT_C6290) (Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation), [NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma), [NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma), [NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma), [NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma), [NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma), [NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma), [NCIT:C136708](http://purl.obolibrary.org/obo/NCIT_C136708) (Uterine Corpus Sarcoma by AJCC v7 Stage), [NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0009853](http://purl.obolibrary.org/obo/UBERON_0009853) (body of uterus) 75.00%
- Thing 51.13%
- [UBERON:0034944](http://purl.obolibrary.org/obo/UBERON_0034944) (zone of organ) 34.28%
- [UBERON:0005156](http://purl.obolibrary.org/obo/UBERON_0005156) (reproductive structure) 31.74%
- [UBERON:0000064](http://purl.obolibrary.org/obo/UBERON_0000064) (organ part) 28.33%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 28.24%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 27.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 27.37%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 26.73%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 26.67%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 26.62%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 26.52%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 26.52%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 26.42%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 26.42%


